Cargando…
Glypican-3 targeted positron emission tomography detects sub-centimeter tumors in a xenograft model of hepatocellular carcinoma
BACKGROUND: Early intrahepatic recurrence is common after surgical resection of hepatocellular carcinoma (HCC) and leads to increased morbidity and mortality. Insensitive and nonspecific diagnostic imaging contributes to EIR and results in missed treatment opportunities. In addition, novel modalitie...
Autores principales: | Labadie, Kevin P., Lehnert, Adrienne L., Kenoyer, Aimee L., Hamlin, Donald K., Ludwig, Andrew D., Utria, Alan F., Daniel, Sara K., Mihailovic, Tara N., Prossnitz, Alexander, Orozco, Johnnie J., Li, Yawen, Wilbur, D. Scott, Miyaoka, Robert S., Park, James O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140215/ https://www.ncbi.nlm.nih.gov/pubmed/37103671 http://dx.doi.org/10.1186/s13550-023-00980-9 |
Ejemplares similares
-
Glypican-3 targeted delivery of (89)Zr and (90)Y as a theranostic radionuclide platform for hepatocellular carcinoma
por: Labadie, Kevin P., et al.
Publicado: (2021) -
Yttrium-90-Labeled Anti-Glypican 3 Radioimmunotherapy Halts Tumor Growth in an Orthotopic Xenograft Model of Hepatocellular Carcinoma
por: Ludwig, Andrew D., et al.
Publicado: (2019) -
Anti-CD45 Radioimmunotherapy with (90)Y but Not (177)Lu Is Effective Treatment in a Syngeneic Murine Leukemia Model
por: Orozco, Johnnie J., et al.
Publicado: (2014) -
cGMP production of astatine-211-labeled anti-CD45 antibodies for use in allogeneic hematopoietic cell transplantation for treatment of advanced hematopoietic malignancies
por: Li, Yawen, et al.
Publicado: (2018) -
Glypicans
por: Filmus, Jorge, et al.
Publicado: (2008)